A multicenter randomized trial of personalized acupuncture, fixed acupuncture, letrozole, and placebo letrozole on live birth in infertile women with polycystic ovary syndrome - PubMed (original) (raw)

doi: 10.1186/s13063-020-4154-1.

Min Hu 1 2, Ernest Hung Yu Ng 3, Elisabet Stener-Victorin 2 4, Yanhua Zheng 5, Qidan Wen 1, Cong Wang 6, Maohua Lai 1, Juan Li 1, Xingcheng Gao 7, Xinhua Wang 1 2, Zhenxing Hu 8, Tian Xia 9, Rongkui Hu 10, Jianping Liu 2 11, Xiaohui Wen 1, Shuna Li 1, Kewei Quan 12, Xingyan Liang 1, Hongcai Shang 2 13, Hongxia Ma 14 15, Jie Qiao 16

Affiliations

A multicenter randomized trial of personalized acupuncture, fixed acupuncture, letrozole, and placebo letrozole on live birth in infertile women with polycystic ovary syndrome

Shiya Huang et al. Trials. 2020.

Abstract

Background: Traditional Chinese medicine (TCM) usually involves syndrome differentiation and treatment. Acupuncture, one form of TCM, requires the selection of appropriate acupoints and needling techniques, but many clinical trials on acupuncture have used fixed acupuncture protocols without accounting for individual patient differences. We have designed a multicenter randomized controlled trial (RCT) to evaluate whether personalized or fixed acupuncture increases the likelihood of live births in infertile women with polycystic ovary syndrome (PCOS) compared with letrozole or placebo letrozole. We hypothesize that letrozole is more effective than personalized acupuncture, which in turn is more effective than fixed acupuncture, and that placebo letrozole is the least effective intervention. Moreover, we hypothesize that personalized acupuncture is more likely to reduce the miscarriage rate and the risk of pregnancy complications compared with letrozole.

Methods/design: The study is designed as an assessor-blinded RCT. A total of 1100 infertile women with PCOS will be recruited from 28 hospitals and randomly allocated to 4 groups: personalized acupuncture, fixed acupuncture, letrozole, or placebo letrozole. They will receive treatment for 16 weeks, and the primary outcome is live birth. Secondary outcomes include ovulation rate, conception rate, pregnancy rate, pregnancy loss rate, changes in hormonal and metabolic parameters, and changes in quality of life scores. Adverse events will be recorded throughout the trial. All statistical analyses will be performed using IBM SPSS Statistics version 21.0 software (IBM Corp., Armonk, NY, USA), and a P value < 0.05 will be considered statistically significant.

Discussion: This study will be the first multicenter RCT to compare the effect of personalized or fixed acupuncture with letrozole or placebo letrozole on live birth in infertile women with PCOS. The findings will inform whether personalized acupuncture therapy can be considered an alternative treatment to improve the live birth rate in infertile women with PCOS.

Trial registration: ClinicalTrials.gov, NCT03625531. Registered on July 13, 2018. Chinese Clinical Trial Registry, ChiCTR1800017304. Registered on July 23, 2018.

Keywords: Acupuncture; Fixed protocol; Letrozole; Personalized protocol; Polycystic ovary syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1

Fig. 1

Moxibustion in the personalized acupuncture group. a 1.5 Moxa sticks used for a treatment session. b Safety lid of the moxa box. c Ignited moxa sticks placed in the moxa box. d The complete moxa box. e The moxa box placed on the abdomen of the patient from the midpoint of the sternal body xiphoid junction and umbilicus to the superior margin of the pubic symphysis. f The moxa box on the back of a patient from the 11th thoracic vertebra to the 4th sacral posterior foramen

Fig. 2

Fig. 2

Study flowchart

Similar articles

Cited by

References

    1. Homburg R. Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18(5):773–788. doi: 10.1016/j.bpobgyn.2004.05.006. - DOI - PubMed
    1. Palomba S, de Wilde MA, Falbo A, et al. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015;21(5):575–592. doi: 10.1093/humupd/dmv029. - DOI - PubMed
    1. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod. 2008;23(3):462–477. doi: 10.1093/humrep/dem426. - DOI - PubMed
    1. Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602–1618. doi: 10.1093/humrep/dey256. - DOI - PMC - PubMed
    1. Legro RS, Brzyski RG, Diamond MP, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014;371(2):119–129. doi: 10.1056/NEJMoa1313517. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources